Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Brazil

100%
Zoom level changed to 1
Global PrEP Tracker
Last Updated: 19 June 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Under Review
Cabotegravir (CAB) for PrEP — ViiV
Approved 2023 2023
Dapivirine Vaginal Ring (DVR) — Pop Council
Not Approved
Oral PrEP TDF/xTC* — Gilead (Truvada)
Approved 2017 2017
Oral PrEP TDF/xTC — generic
Approved N/A N/A
Oral PrEP F/TAF — Gilead
Not Approved
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

4 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

2 Planned/Ongoing Projects

Policy Frameworks

Brazil National PrEP Guidelines, 2018

Est. Cumulative
Initiations:

Total PrEP: 217,683

Oral PrEP: 216,370

Dapivirine Vaginal Ring: N/A

Injectable PrEP: 1,313

Where To Access PrEP in Brazil:

HIV Care Now

Brazil Ministry of Health Database

Featured Resources

External Link

Painel PrEP

The Brazilian government offers this monitoring panel which tracks national data on PrEP delivery.
Document

Central America & Brazil Region ROP, 2022

The goal of the 2022 Regional Operational Plan for the Central American & Brazil region is to maintain progress from 2021 in key areas related to health promotion such as refining efforts to eliminate policy barriers, institutionalizing client- centered services, helping the country achieve 95-95-95, and spotlighting HIV prevention and treatment access for all populations…
Document

Central America & Brazil Region ROP, 2022 (Español)

El objetivo del Plan Operativo Regional 2022 para la región de América Central y Brasil es mantener el progreso desde 2021 en áreas clave relacionadas con la promoción de la salud, como perfeccionar los esfuerzos para eliminar las barreras políticas, institucionalizar los servicios centrados en el cliente, ayudar al país a lograr 95-95 -95, y…
View All Resources